TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,220 | +9.4% | 3,376 | +11.1% | 0.02% | +6.2% |
| Q2 2023 | $47,749 | +6.6% | 3,039 | +11.8% | 0.02% | +14.3% |
| Q1 2023 | $44,799 | +5.6% | 2,718 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $42,407 | +21.2% | 2,718 | +0.4% | 0.01% | 0.0% |
| Q3 2022 | $35,000 | -7.9% | 2,707 | +0.5% | 0.01% | 0.0% |
| Q2 2022 | $38,000 | -2.6% | 2,694 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $39,000 | +5.4% | 2,694 | 0.0% | 0.01% | +7.7% |
| Q4 2021 | $37,000 | -71.3% | 2,694 | -65.8% | 0.01% | -74.5% |
| Q3 2021 | $129,000 | +3.2% | 7,873 | +6.2% | 0.05% | -21.5% |
| Q2 2021 | $125,000 | -1.6% | 7,411 | +6.9% | 0.06% | -9.7% |
| Q1 2021 | $127,000 | +10.4% | 6,934 | +9.2% | 0.07% | 0.0% |
| Q4 2020 | $115,000 | -25.8% | 6,348 | -27.1% | 0.07% | -36.8% |
| Q3 2020 | $155,000 | -0.6% | 8,708 | +0.1% | 0.11% | -8.1% |
| Q2 2020 | $156,000 | +83.5% | 8,698 | +56.9% | 0.12% | +45.9% |
| Q1 2020 | $85,000 | – | 5,543 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |